Nanotech breathing monitor aims to catch silent warnings before It's too late
NCT ID NCT07650539
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new device called RespiraFibre, a tiny sensor that attaches to oxygen masks or tubes to continuously measure breathing rate. Breathing rate is one of the best early signs that a patient is getting worse, but current methods are often inaccurate or skipped. The study will involve 148 hospital patients to see if the device is comfortable, easy to use, and accurate compared to standard monitoring.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- RespiraFibre nanotechnology breathing monitor (device)
- What this could lead to
- If successful, this could give doctors and nurses a simple, accurate way to detect early signs of serious illness in hospital patients, potentially saving lives and reducing costs.
- What could go wrong
- This is an early-stage feasibility study with only 148 participants. The device may not be accurate enough in real-world hospital settings, or patients and staff may find it uncomfortable or difficult to use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY MONITORING are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University College London Hospital
London, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.